أدوية ومنتجات صحية
TARO-CANDESARTAN: affected lots may contain Esomeprazole 20mg capsules
Summary
| Type | Health product recall |
|---|---|
| Product | Taro-Candesartan tablets |
| Issue | Health products - Product quality |
| What to do | Consult your healthcare provider prior to discontinuing use of the affected product or for any health concerns. |
| Distribution | National |
| Brand(s) | Taro |
| Last updated | 2026-11-16 |
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot Number |
|---|---|---|---|---|---|
Taro |
Taro-Candesartan |
DIN 02380692 |
Tablet |
8 mg |
PTG5442A PTG5443A |
Issue
| Affected lots may contain Esomezaprole 20mg capsules. |
What you should do
- Verify if your product is affected.
- Consult your healthcare provider for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Background
Depth of recall: Retailers
Details
| Original published date | 2026-11-17 |
|---|---|
| Alert / recall type | Health product recall |
| Category | Health products - Drugs |
| Companies | Sun Pharma Canada Inc |
| Published by | Health Canada |
| Audience | General public Healthcare Industry |
| Distribution | National |
| Recall class | Type II |
| Identification number | RA-82965 |
Source: Government of Canada, Recalls and safety alerts – https://recalls-rappels.canada.ca/en/alert-recall/taro-candesartan-affected-lots-may-contain-esomeprazole-20mg-capsules